Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
Clinical trial NCT03903913 · UNKNOWN
Trial details
- NCT number
- NCT03903913
- Sponsor
- SolAeroMed Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-08
- Primary completion
- 2022-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.